FDA gives compounders short reprieve as Novo Nordisk GLP-1 supply normalizes
Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...
Zealand Pharma Announces Financial Results for the Full Year 2024
Company announcement - No. 2 / 2025 Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with significant clinical advancement across differentiated obesity pipeli ...
Hosted on MSN2d
MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition
Medifast, Inc. MED delivered fourth-quarter 2024 results, with the bottom and top lines declining year over year. However, ...
Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
Q4 2024 total revenues of $53.2 million, +17% compared to Q4 2023 Q4 2024 Fanapt® net product sales of $26.6 million, +18% compared to Q4 2023 Full year 2024 total ...